Dry Eye Syndrome Treatment Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-09　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 13,290 Mn
2033 年預估規模: USD 38,420 Mn
年複合成長率 CAGR: 16.4%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-02-09頁數 152報告編號 CMI1173

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Dry Eye Syndrome Treatment Market, By Product Type (Cyclosporine, Oral Corticosteroid, Artificial Tears, Omega Supplements, Punctual Bags, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Supermarket/ Hypermarket, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Dry eye syndrome (DES) is also known as keratisis sicca and keratoconjunctivitis sicca. Dry eye disease is a common condition that occurs when your tears aren't able to provide adequate lubrication for your eyes. Patients suffering from DES show damage to the ocular surface, instability in the tear film, and visual disturbance. Tear film covers the ocular surface which is made up of three intertwined layers, a superficial lipid layer produced by meibomian glands assist in reducing tear evaporation and uniform tear spreading, middle thick aqueous layer produced from lacrimal glands, and the innermost hydrophilic mucin layer produced from goblet cells of conjunctiva and epithelium of ocular surface. Dry eye syndrome is associated with a long list of causes which can be divided into primary and secondary. Dry eye may develop secondary to inflammatory disease (e.g. vascular, allergic), environmental conditions (e.g. allergens, cigarette smoke, dry climate), hormonal imbalance (e.g. perimenopausal women and patients under hormone replacement therapy), and contact lens wear. Other causes of dry eye are certain diseases, such as rheumatoid arthritis, Sjögren’s syndrome, thyroid disease, and lupus Blepharitis (when eyelids are swollen or red), Entropion (when eyelids turn in), ectropion (eyelids turn outward) and being in smoke, wind or a very dry climate. Market Dynamics New dry eye therapies are introduced in the market with several new medications in the pipeline seeking approval. Strong product pipeline offers great market growth opportunity as approval of numerous pipeline products is expected to drive the market growth during the forecast period. For instance, in October 2021, Oyster Point Pharma, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease, announce the U.S. Food and Drug Administration (FDA) approval for TYRVAYA (varenicline solution) Nasal Spray 0.03 mg, for the treatment of the signs and symptoms of dry eye disease. YRVAYA Nasal Spray is a selective cholinergic agonist delivered twice daily as an aqueous nasal spray into each nostril to activate basal tear production. Key features of the study: • This report provides in-depth analysis of the global dry eye syndrome treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global dry eye syndrome treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Johnson & Johnson, Inc., I-MED Pharma inc., Santen Pharmaceutical Co., Ltd, AFT Pharmaceuticals, Novaliq GmbH, Otsuka Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries, Inc., Teva Pharmaceutical Industries Ltd., Mitotech, SA, Viatris Inc., among other prominent players • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global dry eye syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dry eye syndrome treatment market Market Segmentation • Product Type Insights (Revenue, USD Mn, 2026 - 2033) o Cyclosporine o Oral Corticosteroid o Artificial Tears o Omega Supplements o Punctual Bags o Other • Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033) o Hospital Pharmacies o Retail Pharmacies o Supermarket/ Hypermarket o Online Pharmacies • Regional Insights (Revenue, USD Mn, 2026 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o AbbVie Inc. o Novartis AG o Bausch Health Companies Inc. o Johnson & Johnson, Inc. o I-MED Pharma inc. o Santen Pharmaceutical Co., Ltd o AFT Pharmaceuticals o Novaliq GmbH o Otsuka Pharmaceutical Co., Ltd. o Sun Pharmaceutical Industries, Inc. o Teva Pharmaceutical Industries Ltd. o Mitotech, SA o Viatris Inc.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Recent Developments o Acquisitions and Partnerships Scenario o Technology Overview o Regulatory Scenario o PEST Analysis o Porter’s Analysis 4. Global Dry Eye Syndrome Treatment Market, By Product Type, 2026-2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Cyclosporine  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Oral Corticosteroid  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Artificial Tears  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Omega Supplements  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Punctual Bags  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends 5. Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2026-2033, (USD Mn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospital Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Retail Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Supermarket/ Hypermarket  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Online Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends 6. Global Dry Eye Syndrome Treatment Market, By Region, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)  Market Size and Forecast, By Country, 2026-2033, (USD Mn) o North Africa o Central Africa o South Africa 7. Competitive Landscape o AbbVie Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Bausch Health Companies Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Johnson & Johnson, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o I-MED Pharma inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Santen Pharmaceutical Co., Ltd  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o AFT Pharmaceuticals  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novaliq GmbH  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Otsuka Pharmaceutical Co., Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Sun Pharmaceutical Industries, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Teva Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Mitotech, SA  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Viatris Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies

提及公司

AbbVie Inc.Novartis AGBausch Health Companies Inc.Johnson & Johnson, Inc.I-MED Pharma inc.Santen Pharmaceutical Co., LtdAFT PharmaceuticalsNovaliq GmbHOtsuka Pharmaceutical Co., Ltd.Sun Pharmaceutical Industries, Inc.Teva Pharmaceutical Industries Ltd.Mitotech, SAViatris Inc.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們